5.11
-0.05(-0.97%)
Currency In USD
| Previous Close | 5.16 |
| Open | 5.12 |
| Day High | 5.26 |
| Day Low | 5 |
| 52-Week High | 11.55 |
| 52-Week Low | 2.35 |
| Volume | 802,692 |
| Average Volume | 519,722 |
| Market Cap | 342.68M |
| PE | -2.3 |
| EPS | -2.22 |
| Moving Average 50 Days | 6.46 |
| Moving Average 200 Days | 5.57 |
| Change | -0.05 |
If you invested $1000 in Eliem Therapeutics, Inc. (ELYM) since IPO date, it would be worth $321.38 as of August 18, 2025 at a share price of $5.11. Whereas If you bought $1000 worth of Eliem Therapeutics, Inc. (ELYM) shares 3 years ago, it would be worth $1,762.07 as of August 18, 2025 at a share price of $5.11.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Data not available
Eliem Therapeutics Announces Rebranding and Corporate Name Change to Climb Bio, Inc.
GlobeNewswire Inc.
Oct 02, 2024 1:00 PM GMT
Name change to "Climb Bio" marks the Company’s transition and focus on developing treatments for immune-mediated diseases Climb Bio will begin trading on Nasdaq under the trading symbol "CLYM" effective October 3rd WELLESLEY, Mass., Oct. 02, 2024 (
Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit
GlobeNewswire Inc.
Sep 11, 2024 11:00 AM GMT
SEATTLE and CAMBRIDGE, United Kingdom, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Eliem Therapeutics, Inc. (Nasdaq: ELYM), announced today members of the management team will participate at the Stifel 2024 Virtual Immunology and Inflammation Summit being h